Bardia Nadim, MD discusses a recently published article on the short-term out-of-pocket and total costs of care after ablation, resection, or transplant for early-stage hepatocellular carcinoma, using national SEER-Medicare data. The analysis reveals significant cost differences among these treatments, with ablation being notably less expensive. Dr. Nadim is joined by Borna E. Dabiri, MD, PhD, who provides insights into the clinical implications, referral processes, post-procedural care, and future research directions.

ARTICLE TITLE - Short-Term Out-of-Pocket and Total Costs of Care After Ablation, Resection, or Transplant for Early-Stage Hepatocellular Carcinoma: A National SEER-Medicare Cost Comparison